Influencer Ohttomom has candidly shared her changed body condition after giving birth to her second child, revealing her ...

Eli Lilly and Company (NYSE: LLY) today announced new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the concomitant use of Taltz (ixekizumab) and Zepbound (tirzepatide) ...

The astrophysicist and author is using her platform to speak out about the feeding challenges those who have undergone double mastectomies face.

"I'm worried if I have enough breast milk.""My baby isn't latching on well.""My breasts are engorged and painful.""I'm not ...

Latest EBGLYSS (lebrikizumab-lbkz) data reinforce durable disease control, less frequent maintenance dosing and reduced ...

More than one in two three-month-old babies are being breastfeed, the highest rate since official records began in 1988, ...

THIS year’s HSE National Breastfeeding Week takes place from October 1 to 7 and is themed ‘Every step forward: Strengthening support for babies and families’, highlighting the important role that ...

Rachael says some mums are being forced to choose between breastfeeding their child and earning a living.

Sienna Miller has strength trained for years, with the focus always on building sustainable results without extreme workouts ...

Before we get to the story, here’s a quick welcome to Mildly Maternal: Diary of a Work In Progress Mom, a weekly check-in on how life is going as a new mom who wasn't sure she wanted to be a mom until ...

Eli Lilly and Company (NYSE: LLY) today announced that EBGLYSS (lebrikizumab-lbkz) monotherapy met its primary and secondary endpoints at Week 16 in the Phase 3b ADtouch study, showing significant and ...